Vol , Issue Date of Publication: July 01, 2004
DOI: https://doi.org/10.20529/IJME.2004.050

Views
, PDF Downloads:

Cashing in on a brand name

Vijay Thawani
K J Gharpure
Abstract:
Consumers in the Third World get third-rate treatment from the pharmaceutical industry, who sell them junk in the name of medicine. This includes formulations banned in the parent country of international giants. These companies have adopted a new technique: marketing new formulations under old brand names without informing consumers. These companies exploit people's faith in brand names and the resistance to generic prescriptions. They also hide behind antiquated laws which do not ban the launch of new formulations using old brand names.


Copyright and license
©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text

HTML | PDF
Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation